306 related articles for article (PubMed ID: 16143308)
1. Inhibition of the transcription factor Yin Yang 1 activity by S-nitrosation.
Hongo F; Garban H; Huerta-Yepez S; Vega M; Jazirehi AR; Mizutani Y; Miki T; Bonavida B
Biochem Biophys Res Commun; 2005 Oct; 336(2):692-701. PubMed ID: 16143308
[TBL] [Abstract][Full Text] [Related]
2. Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis.
Huerta-Yepez S; Vega M; Garban H; Bonavida B
Clin Immunol; 2006 Sep; 120(3):297-309. PubMed ID: 16784892
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide sensitizes prostate carcinoma cell lines to TRAIL-mediated apoptosis via inactivation of NF-kappa B and inhibition of Bcl-xl expression.
Huerta-Yepez S; Vega M; Jazirehi A; Garban H; Hongo F; Cheng G; Bonavida B
Oncogene; 2004 Jun; 23(29):4993-5003. PubMed ID: 15048072
[TBL] [Abstract][Full Text] [Related]
4. The Yin Yang-1 (YY1) protein undergoes a DNA-replication-associated switch in localization from the cytoplasm to the nucleus at the onset of S phase.
Palko L; Bass HW; Beyrouthy MJ; Hurt MM
J Cell Sci; 2004 Jan; 117(Pt 3):465-76. PubMed ID: 14702388
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide sensitizes tumor cells to TRAIL-induced apoptosis via inhibition of the DR5 transcription repressor Yin Yang 1.
Huerta-Yepez S; Vega M; Escoto-Chavez SE; Murdock B; Sakai T; Baritaki S; Bonavida B
Nitric Oxide; 2009 Feb; 20(1):39-52. PubMed ID: 18778787
[TBL] [Abstract][Full Text] [Related]
6. Expression of transcription factor Yin Yang 1 in prostate cancer.
Seligson D; Horvath S; Huerta-Yepez S; Hanna S; Garban H; Roberts A; Shi T; Liu X; Chia D; Goodglick L; Bonavida B
Int J Oncol; 2005 Jul; 27(1):131-41. PubMed ID: 15942652
[TBL] [Abstract][Full Text] [Related]
7. IL-1 beta increases abundance and activity of the negative transcriptional regulator yin yang-1 (YY1) in neonatal rat cardiac myocytes.
Patten M; Wang W; Aminololama-Shakeri S; Burson M; Long CS
J Mol Cell Cardiol; 2000 Jul; 32(7):1341-52. PubMed ID: 10860774
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide inhibits the transcription repressor Yin-Yang 1 binding activity at the silencer region of the Fas promoter: a pivotal role for nitric oxide in the up-regulation of Fas gene expression in human tumor cells.
Garbán HJ; Bonavida B
J Immunol; 2001 Jul; 167(1):75-81. PubMed ID: 11418634
[TBL] [Abstract][Full Text] [Related]
9. Caspase-dependent regulation and subcellular redistribution of the transcriptional modulator YY1 during apoptosis.
Krippner-Heidenreich A; Walsemann G; Beyrouthy MJ; Speckgens S; Kraft R; Thole H; Talanian RV; Hurt MM; Lüscher B
Mol Cell Biol; 2005 May; 25(9):3704-14. PubMed ID: 15831475
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide sensitizes ovarian tumor cells to Fas-induced apoptosis.
Garbán HJ; Bonavida B
Gynecol Oncol; 1999 May; 73(2):257-64. PubMed ID: 10329044
[TBL] [Abstract][Full Text] [Related]
11. YY1 transcription factor is not responsible for the negative regulation of hamster Muc1 transcription.
Hisatsune A; Hyun SW; Lee IJ; Georas S; Kim KC
Anticancer Res; 2004; 24(1):235-40. PubMed ID: 15015602
[TBL] [Abstract][Full Text] [Related]
12. Negative regulation of YY1 transcription factor on the dynamin I gene promoter.
Yoo J; Jeong MJ; Lee SS; Lee KI; Kwon BM; Park YM; Han MY
Biochem Biophys Res Commun; 2001 May; 283(2):340-3. PubMed ID: 11327704
[TBL] [Abstract][Full Text] [Related]
13. Nucleophosmin/B23 regulates PCNA promoter through YY1.
Weng JJ; Yung BY
Biochem Biophys Res Commun; 2005 Sep; 335(3):826-31. PubMed ID: 16099430
[TBL] [Abstract][Full Text] [Related]
14. Rituximab (chimeric anti-CD20) sensitizes B-NHL cell lines to Fas-induced apoptosis.
Vega MI; Huerta-Yepez S; Jazirehi AR; Garban H; Bonavida B
Oncogene; 2005 Dec; 24(55):8114-27. PubMed ID: 16103877
[TBL] [Abstract][Full Text] [Related]
15. YY1 binding to a subset of p53 DNA-target sites regulates p53-dependent transcription.
Yakovleva T; Kolesnikova L; Vukojević V; Gileva I; Tan-No K; Austen M; Lüscher B; Ekström TJ; Terenius L; Bakalkin G
Biochem Biophys Res Commun; 2004 May; 318(2):615-24. PubMed ID: 15120643
[TBL] [Abstract][Full Text] [Related]
16. Synergistic induction of the Fas (CD95) ligand promoter by Max and NFkappaB in human non-small lung cancer cells.
Wiener Z; Ontsouka EC; Jakob S; Torgler R; Falus A; Mueller C; Brunner T
Exp Cell Res; 2004 Sep; 299(1):227-35. PubMed ID: 15302589
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of four novel peptide motifs that recognize distinct regions of the transcription factor CP2.
Kang HC; Chung BM; Chae JH; Yang SI; Kim CG; Kim CG
FEBS J; 2005 Mar; 272(5):1265-77. PubMed ID: 15720400
[TBL] [Abstract][Full Text] [Related]
18. Rituximab-induced inhibition of YY1 and Bcl-xL expression in Ramos non-Hodgkin's lymphoma cell line via inhibition of NF-kappa B activity: role of YY1 and Bcl-xL in Fas resistance and chemoresistance, respectively.
Vega MI; Jazirehi AR; Huerta-Yepez S; Bonavida B
J Immunol; 2005 Aug; 175(4):2174-83. PubMed ID: 16081784
[TBL] [Abstract][Full Text] [Related]
19. Identification of small molecules that sensitize resistant tumor cells to tumor necrosis factor-family death receptors.
Schimmer AD; Thomas MP; Hurren R; Gronda M; Pellecchia M; Pond GR; Konopleva M; Gurfinkel D; Mawji IA; Brown E; Reed JC
Cancer Res; 2006 Feb; 66(4):2367-75. PubMed ID: 16489043
[TBL] [Abstract][Full Text] [Related]
20. In vivo administration of recombinant IL-2 to individuals infected by HIV down-modulates the binding and expression of the transcription factors ying-yang-1 and leader binding protein-1/late simian virus 40 factor.
Bovolenta C; Camorali L; Lorini AL; Vallanti G; Ghezzi S; Tambussi G; Lazzarin A; Poli G
J Immunol; 1999 Dec; 163(12):6892-7. PubMed ID: 10586091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
